Metastatic castration-resistant prostate cancer: new therapies, novel combination strategies and implications for immunotherapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/onc2013497.pdf
Reference112 articles.
1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.
2. NCCN NCCN Clinical Practice Guidelines in Oncology–Prostate Cancer. V1. 2012. Available at http://www.nccn.org Accessed 25 March 2013.
3. Horwich A, Parker C, Bangma C, Kataja V, and on behalf of the ESMO Guidelines Working Group. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 (Suppl 5): v129–v133.
4. Abdollah F, Schmitges J, Sun M, Jeldres C, Tian Z, Briganti A et al. Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis. Int J Urol 2012; 19: 836–844.
5. Maluf FC, Smaletz O, Herchenhorn D . Castration-resistant prostate cancer: systemic therapy in 2012. Clinics 2012; 67: 389–394.
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell response;Epigenomics;2024-03-26
2. Research Progression in the Mechanism of Bone Metastasis and Bone-Targeted Drugs in Prostate Cancer;annals of urologic oncology;2024-02-24
3. Chemotactic signaling pathways in prostate cancer: Implications in the tumor microenvironment and as potential therapeutic targets;International Review of Cell and Molecular Biology;2024
4. Biomarkers of tumor microenvironment of malignant neoplasms of kidneys, urinary bladder, and prostate gland (literature review);Medical alphabet;2022-01-10
5. Strategy and clinical application of up-regulating cross presentation by DCs in anti-tumor therapy;Journal of Controlled Release;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3